2008 position paper on using SSRIs in children and adolescents.
Year: 2009
Type: article
Abstract: This position statement provides an update on the use of Selective Serotonin Reuptake Inhibitors (SSRIs) in the treatment of Major Depressive Disorder (MDD) and Anxiety Disorders in children and adolescents. This paper is not meant to be a comprehensive review of the treatment of anxiety and depression in young people, but a position paper regarding the role of SSRIs in children and youth. As new information regarding the use of SSRIs in young people has become available, the CACAP has updated its position statement on this topic. The current CACAP position is described below and will continue to be updated as new information pertinent to the clinical use of these compounds becomes available.
Source: Europe PMC (PubMed Central)
Authors: E Jane Garland, Stan Kutcher, Adil Virani
Institution: University of British Columbia
Language: French
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1699416284